2026 Q2 Portfolio Activity
In 2026 Q2, Ridgeback Capital Investments L.P. maintained a portfolio of 2 distinct positions. The most significant new addition was Replimune Group Inc., now representing 100.00% of the total fund value. Conversely, Ridgeback Capital Investments L.P. completely exited their position in Pyxis Oncology Inc.
Position History
hover any row below to update
Loading…
Total Positions
2
Quarter
2026 Q2
Top Holding
REPL (100.0%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-2 of 2
Ridgeback Capital Investments L.P. Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
REPL
Replimune Group...
|
Healthcare | 100.00% | — |
#1
Prev: #—
|
9.5 |
—
|
7,310,656 | — |
NEW
|
7,310,656 | $80,928,962 |
$11.07
+16.7%
|
2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
PYXS
Pyxis Oncology ...
|
Healthcare | 0.00% | 100.00% |
Sold All 😨
(Was: #1) |
0.0 |
—
|
-359,231 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-2 of 2 holdings